Raymond DuBois

Raymond DuBois

Medical University of South Carolina

H-index: 120

North America-United States

About Raymond DuBois

Raymond DuBois, With an exceptional h-index of 120 and a recent h-index of 47 (since 2020), a distinguished researcher at Medical University of South Carolina, specializes in the field of Inflammation and Cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Dual blockade of EP2 and EP4 signaling is required for optimal immune activation and antitumor activity against prostaglandin-expressing tumors

Implications of selection bias due to delayed study entry in clinical genomic studies

The First Lady Presses for Cancer Screening to Get Back On Track

The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission

Introducing Cancer Center Director Perspectives on Prevention

Dual blockade of the EP2 and EP4 PGE2 receptors with TPST-1495 is an optimal approach for drugging the prostaglandin pathway

Role of Prostaglandin E2 in the Progression of Gastrointestinal Cancer

The COX-2–PGE2 Pathway Promotes Tumor Evasion in Colorectal Adenomas

Raymond DuBois Information

University

Position

The

Citations(all)

69680

Citations(since 2020)

10205

Cited By

65733

hIndex(all)

120

hIndex(since 2020)

47

i10Index(all)

253

i10Index(since 2020)

138

Email

University Profile Page

Google Scholar

Raymond DuBois Skills & Research Interests

Inflammation and Cancer

Top articles of Raymond DuBois

Dual blockade of EP2 and EP4 signaling is required for optimal immune activation and antitumor activity against prostaglandin-expressing tumors

Cancer Research Communications

2023/8/8

The First Lady Presses for Cancer Screening to Get Back On Track

Cancer Prevention Research

2022/1/1

The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission

2022/11/3

Introducing Cancer Center Director Perspectives on Prevention

2022/11/1

Dual blockade of the EP2 and EP4 PGE2 receptors with TPST-1495 is an optimal approach for drugging the prostaglandin pathway

Cancer Research

2022/6/15

Raymond Dubois
Raymond Dubois

H-Index: 52

Role of Prostaglandin E2 in the Progression of Gastrointestinal Cancer

2022/6/2

The COX-2–PGE2 Pathway Promotes Tumor Evasion in Colorectal Adenomas

Cancer Prevention Research

2022/5/3

The Urgent Need for Expanded Cancer Screening

Cancer Prevention Research

2021/12/1

Cyclooxygenases and prostaglandins in tumor immunology and microenvironment of gastrointestinal cancer

2021/12/1

Mutant APC promotes tumor immune evasion via PD-L1 in colorectal cancer

Oncogene

2021/10/14

Meeting report: translational advances in cancer prevention agent development meeting

Journal of Cancer Prevention

2021/3/3

COVID-19, cancer care and prevention

Cancer Prevention Research

2020/11/1

Fibroblasts fuel intestinal tumorigenesis

Cell research

2020/8

Prostaglandin E2 induces miR675-5p to promote colorectal tumor metastasis via modulation of p53 expression

Gastroenterology

2020/3/1

See List of Professors in Raymond DuBois University(Medical University of South Carolina)

Co-Authors

academic-engine